ASHP Advantage: Pharmacist Education on Immunotherapy: An Investment into the Patient as a Team Member in irAE Management

This discussion highlights the importance of pharmacist education of patients on immunotherapy, and barriers that may prevent patients from becoming active participants in the identification and management of irAEs.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.